SCHEMBL4617355

SCHEMBL4617355

COc1ccc(Sc2ccc(CN3CCC(c4cc(NC(=O)C5CCNCC5)ccc4C)CC3)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.52
HSP90AB1 P08238 1/20 0.52
DRD2 P14416 2/20 0.51
ADRA1A P35348 1/20 0.51
PRKAB2 O43741 1/20 0.46
PRKAG1 P54619 1/20 0.46
PRKAA2 P54646 1/20 0.46
PRKAA1 Q13131 1/20 0.46
PRKAG3 Q9UGI9 1/20 0.46
PRKAG2 Q9UGJ0 1/20 0.46
PRKAB1 Q9Y478 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
HPGD P15428 2/20 0.46
POLB P06746 2/20 0.46
NPC1 O15118 1/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
NFKB1 P19838 1/20 0.46
HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4617067 0.91 HSP90AA1 (0.50) HSP90AA1HSP90AB1DRD2ADRA1ACTNNB1
SCHEMBL4808233 0.88 DRD2 (0.57) HSP90AA1HSP90AB1DRD2ADRA1AALDH1A1
SCHEMBL4617135 0.85 DRD2 (0.69) DRD2ADRA1A
SCHEMBL4615106 0.85 DRD2 (0.53) DRD2ADRA1ASMN1; SMN2POLBPTGIR
SCHEMBL4617186 0.84 HSP90AA1 (0.46) HSP90AA1HSP90AB1DRD2ADRA1ACTNNB1
SCHEMBL4617356 0.83 DRD2 (0.51) DRD2ADRA1APRKAB2PRKAG1PRKAA2
Hydrochloric Acid SCHEMBL4857498 0.82 DRD2 (0.74) HSP90AA1HSP90AB1DRD2ADRA1ARAB9A
SCHEMBL4615443 0.82 DRD2 (0.50) DRD2ADRA1ASMN1; SMN2LMNAALDH1A1
Hydrochloric Acid SCHEMBL4854154 0.81 DRD2 (0.61) HSP90AA1HSP90AB1DRD2ADRA1APRKAB2
SCHEMBL4617774 0.80 DRD2 (0.54) DRD2ADRA1ASMN1; SMN2HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080139555-A1 Arylthiobenzylpiperidine Derivatives H. LUNDBECK A/S (DK) 2008-06-12 US disclosed
US-7329656-B2 Arylthiobenzylpiperidine derivatives H. LUNDBECK A/S (DK) 2008-02-12 US disclosed
EP-1799223-A4 ARYLTHIOBENZYLPIPERIDINE DERIVATES LUNDBECK & CO AS H (DK) 2008-01-23 EP disclosed
EP-1799223-A2 ARYLTHIOBENZYLPIPERIDINE DERIVATES H.Lundbeck A/S (DK) 2007-06-27 EP disclosed
WO-2006041635-A2 ARYLTHIOBENZYLPIPERIDINE DERIVATIVES H. LUNDBECK A/S (DK) 2006-04-20 WO disclosed
US-20060079683-A1 Arylthiobenzylpiperidine derivatives H. LUNDBECK A/S (DK) 2006-04-13 US disclosed
US-20060079523-A1 N-[3-(1-{[4-(4-fluorophenylthio)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide; melatonin-concentrating hormone (MCH1) receptor ligand; antidepressant, anxiolytic, antidiabetic agent H. LUNDBECK A/S 2006-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060079523-A1 N-[3-(1-{[4-(4-fluorophenylthio)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide; melatonin-concentrating hormone (MCH1) receptor ligand; antidepressant, anxiolytic, antidiabetic agent MCHR1, MTNR1A, MTNR1B HSP90AA1 3867/4885HSP90AB1 3917/4885DRD2 156/4885
US-20080139555-A1 Arylthiobenzylpiperidine Derivatives MCHR1, MC4R, MCHR2 HSP90AA1 2353/4885HSP90AB1 2211/4885DRD2 210/4885
US-20060079683-A1 Arylthiobenzylpiperidine derivatives MCHR1, MC4R, MCHR2 HSP90AA1 2541/4885HSP90AB1 2370/4885DRD2 217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.